Providers’ perspectives on what heroin-assisted treatment ought to be: a qualitative study Authors: Marja Leonhardt, Rune Ellefsen, Vegard Kokabzadeh Haukland, Linda Elise Couëssurel Wüsthoff Published: 2026 ABSTRACT BackgroundHeroin-assisted treatment (HAT) is an option for opioid use disorder (OUD), particularly for individuals not adequately served by standard therapies like methadone. Studies indicate that HAT can reduce criminal activity and enhance integration into society, as evidenced by significant long-term benefits in employment and health outcomes for marginalised populations. The Norwegian HAT program, launched in 2022, aims to complement existing opioid agonist treatments and improve health outcomes for those with OUD. This study seeks to explore clinicians’ perspectives on the ideal structure of HAT and identify challenges that may affect its implementation.MethodsThis qualitative study employed an explorative design, conducting 21 semi-structured individual interviews with clinicians from the Norwegian HAT, including one interview with two clinicians. Individual interviews were chosen to facilitate open discussions about their experiences and views on HAT. Analysis was performed using Braun and Clarke’s reflexive thematic analysis framework to identify key themes and patterns from the transcripts.ResultsFour overarching themes were identified, whereof the first three were interrelated. The themes reflect clinicians’ ideal treatment philosophy and perspectives on what heroin assisted treatment ought to be: (1) An individualised and patient-centred treatment, (2) A holistic approach with an interdisciplinary collaboration, (3) A flexible service, and (4) Incorporating substance use as a reality.ConclusionThe clinicians’ insights outlined a comprehensive vision of HAT grounded in the principles of individualisation, holistic care, flexibility, and a realistic understanding of substance use. They found it essential to integrate medical, psychological, and social support while fostering collaboration among healthcare professionals. This framework not only responds to the complex realities of addiction but may also support pathways toward recovery, according to clinicians. These insights indicate a need for policy changes within the Norwegian HAT and resources that empower comprehensive care strategies within opioid agonist treatment frameworks. Background Heroin-assisted treatment (HAT) has become known as an effective treatment for opioid use disorder (OUD), expanding the range of evidence-based options available to individuals whose needs may not be adequately met by conventional opioid agonist treatments like methadone [1]. In HAT, people with severe OUD receive pharmaceutical heroin (diacetylmorphine), administered either through injection or orally under medical supervision. A review of randomised-controlled trials suggest that HAT not only contributes to reduced criminal activity but also to improve integration within society [2]. German studies have shown that long-term outcomes of HAT also point to significant improvements when it comes to integration into employment [3, 4]. Transitioning patients from methadone maintenance treatment to HAT has further shown to provide substantial health benefits and reductions in street drug use, further confirming the efficacy of this treatment modality [5, 6]. Moreover, HAT may also offer advantages in healthcare access for marginalised populations like people with severe OUD. By integrating HAT with primary care services, it may enhance health outcomes while simultaneously reducing reliance on emergency healthcare [7]. The high running costs of HAT relative to conventional treatments such as methadone have contributed to funding instability in the UK, as illustrated by the decommissioning of the Middlesbrough diamorphine-assisted treatment service in 2022 after insufficient funds were allocated for its continuation [7]. Thus, recent investigations into the dynamics of HAT have shown complexities in its delivery, particularly regarding treatment adherence and diversion of prescription medications. A study found that patients desire more autonomy over their treatment, which can lead to medication diversion, and overdose risk [8]. These findings underscore the importance of context and implementation when designing successful HAT programmes, as the environment in which treatment is delivered greatly influences patient outcomes [1]. HAT is available in eight countries in Europe and Canada [9]. There is a variation among the countries in the number of clinics where HAT is available, medication route options (injectable, tablet, inhalation, and intranasal), and criteria for inclusion/exclusion from treatment. While the evidence base for HAT is large, qualitative research exploring provider experiences has highlighted the tensions clinicians navigate between therapeutic ideals and institutional constraints [10]. The Norwegian HAT programme was initiated by the Norwegian Directorate of Health in the spring of 2020, following decades of opiate agonist treatment (OAT) being the primary treatment, involving methadone and buprenorphine. Operating in a day-centre model, the HAT programme provides treatment at two designated clinics in Oslo and Bergen. Patients receive diacetylmorphine twice daily, administered by medical personnel, alongside take-home dose of a slow-releasing opioid agonist as bridge medication overnight. Unlike in Switzerland [11], take-home doses of diacetylmorphine are not offered, requiring the patients to attend the clinics every day throughout the year. Admission criteria to HAT include being diagnosed with an OUD, at least one unsuccessful attempt at standard OAT, being over 18 years old, and residing in the catchment area of the HAT clinic. Individuals with severe mental disorders affecting treatment adherence, women who are pregnant, or those with a history of violent behaviour are excluded from HAT. The HAT programme was officially launched in the winter of 2022, functioning alongside existing OAT provisions, and aims to evaluate HAT as an addition to existing OAT in Norway, and further, to improve the health outcomes and overall quality of life for individuals struggling with opioid dependence. In 2021, the Norwegian Centre for Addiction Research (SERAF) at the University of Oslo was selected to evaluate the programme, collaborating with several institutions, including the Section for Clinical Addiction Research at Oslo University Hospital, the Bergen Addiction Research Group, the user organisation proLAR Nett and the Centre for Alcohol and Drug Research at Aarhus University, Denmark [12]. Norwegian research exploring patient treatment experiences in HAT showed that patients were generally satisfied, and their contentment was influenced by various factors including relational and socio-environmental aspects, which can either enhance or hinder treatment retention [13]. Health-related quality of life (HRQoL) assessments revealed difficulties faced by patients, particularly in areas such as pain/discomfort and anxiety/depression, although a majority of participants were able to maintain a consistent level of HRQoL throughout their treatment, indicating the importance of personalised care and support tailored to individual needs [14]. In a study by Ellefsen et al., clinicians in HAT in Norway similarly reported a duality in their experiences, finding rewards in harm reduction, holistic care, and positive patient relationships, while facing challenges related to dosing risks, rule enforcement, and the complexities of treating patients who show behavioural instability and fluctuating substance use patterns [15]. However, that study focused primarily on the everyday challenges of providing HAT rather than on the underlying treatment philosophy guiding clinicians’ practice. The present study builds on this work by conducting new interviews and explicitly exploring what clinicians perceive as the ideal concept of HAT. British research showed that HAT improves healthcare access and outcomes for marginalised communities, as shown by increases in health-related interactions such as wound care appointments and routine health screenings. The program has led to reductions in emergency healthcare utilisation, including decrease in unplanned emergency interactions and overnight hospital stays, resulting in cost savings for the healthcare system [7, 10]. These facets of HAT raise questions about how clinicians conceptualise and navigate the delivery of such a complex intervention. Understanding clinicians’ perceptions of the ideal structure of HAT, including factors such as patient autonomy, healthcare access, and the balance between medical management and psychosocial support, is essential for improving existing HAT programmes, but also for informing the design of future programmes and supporting evidence-based expansion into new settings. Additionally, identifying barriers and challenges to realising the ideals provides important information that can further help to optimise treatment more in line with those ideals. Thus, the purpose of this study was to investigate clinicians’ perspectives on what they see as the ideal concept of HAT, by analysing how they describe their treatment practices and treatment aims, which illustrate their underlying treatment philosophy. Methods Design, setting and participants This study was conducted within the scope of the qualitative part of the evaluation of HAT in Norway, which comprised individual interviews with patients and relatives and (focus group) interviews with staff at different timepoints within the project phases. To answer the research question, we adopted an explorative design, conducting 21 semi-structured individual in-depth interviews and one semi-structured in-depth interview with two clinicians together. The present study corresponds to the Standards for Reporting Qualitative Research [16]. The study was conducted in the two clinics which provide HAT within the five-years-project-phase in Norway. The clinics differ in terms of number of patients, staffing, location and opening hours. An overview of the characteristics of the HAT clinics in Oslo and Bergen is shown in Table 1. Table 1Characteristics of the Norwegian HAT clinicsOsloBergenCatchment area? [17]523,400465,200Number of patients in OAT programmes (excl. HAT) [17]1,1411,109Patients in HAT¹5128Opening hours for patients8:15 − 11 am (observation open until 12 am), 2–4 pm for injection and until 5 pm for tablets8:30 − 11 am and 2–4 pm for injection and until 5 pm for tabletsStaffing at weekdays8 nurses (4 early shift 8 am-3:30pm, 4 late shift: 10 am-5:30pm), 2 social worker, 1 clinic manager, 1 physician, 1 administrative worker8–10 clinicians (5 nurses,1 physician, 1 clinic manager, 1 psychologist, 1 social worker, 1 administrative worker)Staffing in the weekend6 nurses1 support worker5 nursesPhysician coverage1 physician 100% (5 days per week) – on call at weekends1 physician 40% (1.5 days per week) – on call at weekendsPsychologist coverageNone,referral to other units for counselling with psychologist20% (1 day per week)LocationCampus at Oslo University Hospital next to the OAT clinicIn the city centre, ground floor of a building housing several specialist health care and research units in the field of addiction¹Status, 15.10.2025 Table 1Characteristics of the Norwegian HAT clinicsOsloBergenCatchment area? [17]523,400465,200Number of patients in OAT programmes (excl. HAT) [17]1,1411,109Patients in HAT¹5128Opening hours for patients8:15 − 11 am (observation open until 12 am), 2–4 pm for injection and until 5 pm for tablets8:30 − 11 am and 2–4 pm for injection and until 5 pm for tabletsStaffing at weekdays8 nurses (4 early shift 8 am-3:30pm, 4 late shift: 10 am-5:30pm), 2 social worker, 1 clinic manager, 1 physician, 1 administrative worker8–10 clinicians (5 nurses,1 physician, 1 clinic manager, 1 psychologist, 1 social worker, 1 administrative worker)Staffing in the weekend6 nurses1 support worker5 nursesPhysician coverage1 physician 100% (5 days per week) – on call at weekends1 physician 40% (1.5 days per week) – on call at weekendsPsychologist coverageNone,referral to other units for counselling with psychologist20% (1 day per week)LocationCampus at Oslo University Hospital next to the OAT clinicIn the city centre, ground floor of a building housing several specialist health care and research units in the field of addiction¹Status, 15.10.2025 Characteristics of the Norwegian HAT clinics 6 nurses 1 support worker None, referral to other units for counselling with psychologist ¹Status, 15.10.2025 The study population comprised 18 female and five male clinicians (Fig. 1), including 12 who were or had been employed at the clinic in Bergen and 11 at the clinic in Oslo. Among the nurses and clinical social workers, the majority has been in touch with persons who inject drugs (PWID) at their previous workplace in psychiatry or addiction services. Only two nurses had no previous experiences with PWID. The physicians were both specialists in addiction medicine, and both clinic managers had a background in nursing and social work, respectively, with longstanding experience in the field of addiction. Among the former employees, there was one with working experience from a low-threshold facility for persons with ongoing substance use, and two with working experience from addiction services, prior to working in HAT. The age in the study population was ranging from 24 to 65 years. Fig. 1Study sample Study sample Data generation Prior to conducting the interviews, the first author was a participant observant over two-three days in both clinics, to get insights into the daily procedures and to inform the clinicians about the study. Based on the participant observation, the semi-structed interview guide which had been used in previous focus groups with clinician [18] was enhanced and adjusted towards the aim of this study. The interview guide included open-ended questions on work experience and education; the daily work with patients; changes and adjustments in the clinic; leadership, collaborations and resources; working environment; inspiring and challenging episodes; and future perspectives. To keep the interview open, there was no explicit question on what type of treatment HAT ought to be, but we gathered expressions covering this from across the other questions. The interview guide was sent to the extended research group, including quantitative researchers and clinicians, who were in charge of the evaluation of the entire project. This led to a slight modification of the interview guide, without changing the main topics. Participants in Oslo were recruited with help of the charge nurse, scheduling the interviews for the first author. Participants in Bergen were recruited by the first author, while spending time at the clinic. We used purposive sampling as we intended to gain insight from all different occupational groups, working as clinicians in HAT [19]. To explore an even broader perspective about what treatment HAT ought to be, we additionally contacted via current employees five former clinicians who terminated their position in the HAT clinics due to various reasons. Contact with former clinicians was made possible through their prior involvement in the evaluation project, within the scope of the existing ethical approval. As the total clinician workforce across both HAT clinics was small, we aimed to interview as many clinicians as possible to capture the full range of perspectives within this professional community. Rather than pursuing data saturation in the conventional sense, our sampling strategy was guided by the goal of maximum inclusion, aimed at depth and richness of meaning rather than data sufficiency [21]. The interviews lasted between 55 and 75 min and were all conducted in Norwegian by the first author between March and June 2025. The interviews with the current clinicians took place face to face in a separate examination room within the respective clinics, whereas the interviews with the former clinicians were conducted digitally via Microsoft-Teams. Three interviews were interrupted by colleagues who had urgent questions for the interviewee, as per clinic procedures. These interruptions extended the duration of the interviews, as each one had to be resumed after the interruptions. This disruption not only prolonged the interviews but may have also affected the flow and continuity of the conversation. Analysis We recorded the individual interviews and created verbatim transcripts. We utilised the reflexive thematic analysis (RTA) with an inductive approach outlined by Braun and Clarke [20] to illuminate and understand our participants’ professional experiences and perceptions regarding HAT. The analysis was grounded in a constructionist epistemological position, consistent with Braun and Clarke’s conceptualisation of RTA [21]. Rather than assuming a single objective reality, this orientation holds that meaning is co-constructed between participants, researchers, and the broader sociocultural context. RTA includes the following six steps: (1) engaging with the data, (2) generating initial codes, (3) identifying initial themes, (4) reviewing the themes, (5) defining and naming themes, and (6) writing the final report. For the analysis, the first author repeatedly listened to the recordings and closely examined the transcripts to uncover both explicit and implicit meanings, then developed codes that condensed key components of meaning and organised themes by recognising patterns across the transcripts. While the first author led the coding process, all co-authors engaged iteratively with the data and emerging themes throughout the analysis, returning to the transcripts as needed during team discussions to ensure themes were grounded in the data. Subsequently, mind mapping techniques were employed to categorise the codes into final themes, illustrating the overall conceptual structure of data patterns and their interconnections (see Fig. 1). All quotes were translated from Norwegian to English with help from GPT UiO, a service developed by the University of Oslo (UiO) that allows researchers to use OpenAI’s GPT models within UiO’s privacy requirements. Translations were then verified by a bilingual speaker to ensure accuracy. Researchers’ reflexivity We used the principles of RTA by engaging researchers with different analytical perspectives in the analytical process. All interviews were conducted by the first author (ML), a mixed-methods researcher with previous experience working with service users within a needle exchange program in Germany. The research team involved in data analysis consisted of a multi-disciplinary team, comprising a psychiatrist and community medicine specialist (LECW), a sociologist and PhD student (VKH) and a criminologist and qualitative researcher (RE). Members of the research team have a broad range of academic and working experience in the field of addiction and research. All members of the research team have knowledge and experience in qualitative research methodology. Rather than aiming to minimise researcher influence, we incorporated our positionalities as an active part of the analytical process. Our embeddedness in the broader HAT evaluation project, while providing valuable contextual knowledge and establishing trust with participants, also meant that clinicians may have been aware of our prior work and institutional affiliations, which may have shaped what they chose to share and how. We used team discussions and mind mapping not to reach consensus on a single correct interpretation, but to interrogate our individual readings of the data and generate analytically robust themes through dialogue [21]. Our constructionist orientation informed this reflexive process throughout, acknowledging that our own positionalities and prior experiences in addiction treatment and research shaped the analytical lens. Ethics This study was conducted in line with the Norwegian guidelines for medical and health research and in compliance with the Declaration of Helsinki (https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/). The study did not involve any patients or service users. The overall evaluation project this study is part of was approved by the Regional Ethical Committee from South-East Norway (reference number 195733) as well as the local Data Protection Officers in Bergen Health Trust (3061–3061) and Oslo University Hospital (20/27594). All data were handled and stored in line with regulations for health research and sensitive personal data. Written informed consent was obtained from the clinicians prior to the interviews. All presented interview-quotes are pseudonymised, using Px as an identifier. To maintain anonymity of the interviewees, in the following all employees are referred to as “clinicians”. Results We identified four overarching themes whereof the first three were interrelated dimensions of clinicians’ broader treatment philosophy. While interconnected, each theme captures a analytically distinct aspect of that philosophy: Theme 1 concerns the relational and individualised orientation toward each patient; theme 2 concerns the structural and professional conditions, interdisciplinary collaboration and holistic care, needed to realise that orientation; and theme 3 concerns the operational and institutional flexibility required to put both into practice. Theme 4 stands apart, addressing clinicians’ position toward the reality of ongoing substance use and the role of stigma and tolerance within the treatment philosophy (Fig. 2). Fig. 2Final thematic map, generating themes from codes Final thematic map, generating themes from codes Theme 1: Individualised and patient-centred treatment The first theme which emerged describes how clinicians think HAT is intended to promote a supportive and nurturing environment that addresses the unique needs of each patient, while also navigating the complexities of treatment delivery. Clinicians emphasised the necessity of tailoring HAT to incorporate patients’ individual needs. They reported how they individually evaluate the intoxication status and general condition of each patient twice a day, before the patient may receive diacetylmorphine and to which dosing. The clinicians explained that an individualised approach should allow for flexibility in treatment plans, particularly when patients express unique requirements related to their general condition and needs. One clinician mentioned a particular case:“… we made an exception for one patient who was in a very good status in terms of substance use, and who had started cycling, you know, and wanted to participate in cycling and spinning and all that kind of stuff. And then he said: ‘If I take the whole afternoon doses now, I won’t manage to cycle.’ So, he was allowed to take a little with him.” (P6). Another clinician reinforced this perspective, stating, “When you are working with HAT, it is always a very individual treatment, right? So, one should try to see each individual.” (P15). One clinician explained that this dedication to recognising individual needs serves as a foundation for the ideal treatment philosophy in HAT. Also fostering an individual relationship between clinicians and patients was highlighted as an important element for successful HAT. One clinician shared her observation of the positive interactions that take place within the observation room: “And I also experience that there can be something very … that there are very many nice moments here. We talk about what’s on today’s news and what they think about Trump and so on, but also about their feelings on that particular day” (P1). The interviewee meant that these sometimes totally ordinary interactions contribute to patients’ satisfaction and adherence with the treatment. This was supported by another clinician, “They are quite satisfied with HAT. They have good relationships with us, because we see them each as independent persons and not as just ‘the patients’, we have to be aware of this” (P11). The establishment of a reliable relationship fostered trust and encouraged patients to engage more fully in their treatment. Such interactions underlined the importance of consistent engagement with patients over time, which one clinician identified as “a key to success here.” (P15). The promotion of patient autonomy arose as an aspect of the ideal HAT philosophy. One clinician said, “I also would have expected much more violence and threats from that patient group, and I think there is very little. We have to cheer on these people, we have to give them a feeling of mastery […] there are, of course, discussions, disagreements, a bit of shouting, and things like that, but it’s nothing compared to what I am used to from other low-threshold services, because we can relate purposefully to each individual.“(P15). This reflection, while illustrating positive reappraisal of patient behaviour, also reveals a preconception about people with OUD that connects to the broader issue of clinician stigma explored in Theme 4. The clinicians also recognised the challenges that patients face in achieving their treatment goals. One stated, “Well, this is a publicly funded clinic. But I really feel that the patients often have to fight very hard to achieve the treatment goals they want, or the dose of diacetylmorphine they feel has the best effect.” This observation tells a tension between the ideal of patient autonomy and the actual power dynamics operating within HAT. While clinicians expressed a philosophical commitment to autonomy, decisions about dosing, routes of administration, and treatment goals still remain within clinical control. To enhance effective treatment and patient autonomy, one clinician suggested, “We need more time for the patients, more help to discover what their strengths, dreams and desires are with [in the context of] HAT. This is so extremely important. Because they get disappointed all the time anyway, but at least we should have tried.”(P17). Theme 2: Holistic approach with interdisciplinary collaboration The second theme was interrelated to the first theme and highlighted how important it is to integrate medical, social, and psychological support in HAT. Clinicians expressed a desire to improve communication between patients and providers, to create a supportive environment that addresses patients’ diverse needs and improves their recovery and quality of life, but this was often hindered by the treatment organisation’s structure. A core component of HAT according to the clinicians should be the comprehensive medical treatment provided to patients at the clinics. The clinicians reflected that HAT should include much more than merely administering medication, as one stated, “… we provide stabilisation, and we also have everything the social workers offer regarding housing situations and finances, and disability support, and we connect a lot of partners and have very close follow-up with housing…” (P12). Another clinician noted that relying solely on medications would likely not lead to improvements in patients’ conditions. They emphasised that the efforts of social workers are crucial, suggesting that for many patients, social support may play a more vital role than medication in addressing the complexities of their chaotic lives. One clinician highlighted the importance of a comprehensive support system, mentioning that successful treatment involves not only providing necessary medications but also helping patients establish a more stable framework for their lives through various services, such as dental care and access to welfare services. Physicians and nurses reported that they assisted patients in scheduling appointments with general practitioners and other specialists, while the social workers highlighted their role in helping patients navigate social welfare appointments and allowances. Although not all clinicians believed they were delivering a fully holistic treatment, many acknowledged that there was potential to offer more comprehensive services. One clinician pointed out that there was a lot of time during clinic hours to assist patients, expressing that they could engage in various supportive actions, such as providing additional conversations and care. They expressed a desire for more holistic engagement with patients, but experienced that they did not use the existing structure efficiently, with one stating, “… I think we should be able to do this, because if there is something we have time for in the clinic, it is to help our patients. We have a lot of downtime. A lot. And we have plenty of time to help them, we have plenty of time for conversations, we have plenty of time to… we could have accompanied them to IKEA, we could have taken them to the emergency room, we would have had time for everything, just like it is now [within the current structure].” (P6). Some interviewees meant that there is a need for educating and informing the patients as part of the treatment framework, reinforcing that medication should not be viewed as a panacea. Some recognised the limitations of simply increasing medication dosage. One clinician puts it like this: “… And we have certainly seen, that simply increasing doses has little effect. The development of tolerance means that they just have to increase the dose more. So, working with patients psycho-educatively, meaning helping them to understand how this works, is important.” (P21). One clinician also reflected on the importance of emotional resilience within the patient population, “Many of the nurses tend to focus on the idea that medication is the solution to everything. Meanwhile, I believe it’s also important for this patient group to learn to experience a certain level of discomfort and to be able to endure it and work through it without necessarily taking a pill.” (P9). Social support and the promotion of social activities were further mentioned as essential elements in HAT. The clinicians expressed the intention to guide patients towards meaningful engagement in society and away from potentially harmful behaviours. One clinician suggested, “So perhaps, when they are in the observation room, one might encourage referrals to social activities, rather than just observing them.” (P16). The clinicians also recognised the potential for positive change through individual support, which can lead to improvements in patients’ lives: “It’s important with social support, where you get help to gain an overview and manage your finances and housing and all that. There’s a lot that can be accomplished there. You know, for some patients, they needed this piece, that piece, and that piece, and then they’re able to make a lot of positive changes.” (P3). An interdisciplinary collaboration was also said to be important for a holistic treatment approach. The nurses expressed the value of coordination among professionals, but not all the interviewees felt they did that, “We actually don’t have the opportunity for that. We are quite constrained at the different posts in the clinic, but we do try to follow up, if we have the opportunity, we try to accompany them to their general practitioner.” (P12). Especially the nurses recognised challenges within the present setting but also reported willingness to seek ways to facilitate better care. One clinician offered insight into his role within a larger system: “And we are just a tiny part of it. But if we can be a positive part and help to diminish the craving for substances, help them to get a bit control in life, then a lot tends to happen on its own, as we have seen.” (P15). The importance of inclusive collaboration was further believed to be an important part of the ideal HAT philosophy: “We can also have collaborative meetings where the provider, patient, social worker, and any other relevant individuals can be invited. I think we are good at this type of meetings when it comes to ensuring the smoothest process and the best flow for the patient.” (P7). Theme 3: A flexible service Also, the third theme which emerged from the interviews – HAT as a flexible service – is interrelated to the first two themes and underscored the clinician’s wish to operate dynamic, flexible and to continuously learn to better meet the needs of their patients. The clinicians noted the importance of accessibility for patients, recognising that flexible service hours could greatly benefit the patient population. One clinician remarked that “we must not be so rigid and could have longer opening hours,” reflecting a need to adapt to the diverse and complex needs of their patients. The interviewees explained that the profiles of the majority of patients being referred to HAT are increasingly complex, with many patients presenting comorbid somatic, mental health, and violence-related histories. This posed a challenge that clinicians felt compelled to meet within existing structures, as one clinician noted, “These are the patients we get referred. And we have to try to make it work within the framework we have.” (P15). As the service progressed, the clinicians were aware of the continuous development required to successfully treat new patients. They faced challenges in helping patients differentiate between being stabilised on medication and continuing illicit heroin use. One clinician pointed out that “learning the difference between being stable and medicated versus using street heroin… has also been a development that has taken time for us as staff to understand.” This was characterised by a lack of definitive guidelines, as one clinician emphasised, “There is usually no definitive answer… there is not even anything that resembles a definitive conclusion”(P3). However, not all clinicians shared this orientation equally. Some expressed that a degree of predictability and consistent rule enforcement was necessary to maintain a safe and functional clinical environment, and that too much flexibility risked undermining the structure that both patients and staff relied upon. This tension between adaptability and structure was an ongoing negotiation within the clinics rather than a resolved consensus. In light of the complexities involved, clinicians found themselves in constant discussions about the nuances of patient care, including how long individuals should remain in treatment and how to address the additional use of other illicit substances. They reflected that they are in a process that is both challenging and necessary, “…we maybe haven’t really known how to do such things, so we have, in a way, fallen into some traps, but have found good solutions.” (P16). One clinician explained that “…since it is a project that is constantly evolving, we are continuously reviewing routines,” (P12) particularly in response to what they identified as ineffective practices. The same clinician said that adjustments around procedures, such as handling blood alcohol levels or how to proceed if a patient doesn’t show up for several days, are vital: “…we have gotten a bit more of these standard procedures for things that are somewhat simpler, but we still have to be flexible.” The clinicians admitted that the developing nature of the HAT program in Norway necessitates the continuous reconsideration of procedures and routines to provide and ensure a flexible service. Theme 4: Incorporating substance use as a reality The fourth theme stands distinct from the three preceding themes. The clinicians emphasised the importance of adopting a realistic approach to addiction. They recognised that many patients often engage with HAT primarily to address their substance use needs. As one clinician noted, the motivation for seeking treatment can often be straightforward: “Even though we wish they wouldn’t come because of that, they actually come just to get high and chase that rush” (P2). While this observation reflects an honest and pragmatic acceptance of patients’ motivations, the wish that patients would engage for different reasons also reveals an underlying tension between harm reduction principles and more recovery-oriented treatment ideals. This recognition of patient motivations led to discussions on accommodating these realities, such as considering the provision of higher doses during special occasions to align with societal norms. One clinician illustrated this thought, “An extra birthday dose? I don’t know, it could probably be nice. Well, that’s just how their life is. ‘Now it was a friend who had a birthday, I arranged some extra pills for him.’ That’s how they celebrate. I also celebrate by getting drunk on my birthday.“(P15) The clinicians also shared their frustrations regarding the complexities of treatment, admitting that they face difficulties when patients struggle to manage their addiction. Despite these challenges, clinicians expressed that they were also coping with stigmatisation, as one acknowledged, “If I’m not within my tolerance window, I can think: ‘But can’t you just stop taking drugs though?’ So of course, I have prejudices too, but I am actively trying to work against that ….” (P23). The clinicians were aware that they themselves are not free from prejudice and believed that they should be grapple with it. Another clinician described directly challenging a stigmatising attitude among colleagues, “…when we are sitting in a meeting and actually discussing an issue, and a colleague says: ‘Yes, but he chose that himself,’ then I say: ‘No, he did not.’” They explained that it should be essential if you work in HAT to be open minded towards the patient group, who might be exposed to suspicious attitudes outside the treatment. “We are quick to suspect that it all has to do with additional illicit substance use, but it could be some other issues the patient has, and this is not a constructive posture.”(P19) Another clinician mentioned that the terminology used to refer to individuals - whether as “patients” or “clients”- plays a significant role in shaping treatment dynamics and identity. He recognised that such language choices affect how patients engage with the system, observing that “it affects how you approach the system, how you experience the system, and how the system sees you.” (P17) This sensitivity to terminology highlights a deeper reflection on equity and impartiality within clinical settings. Another clinician admitted that “I find it challenging to educate the rest of the support system about HAT; reducing the stigma associated with treating patients with heroin use is absolutely challenging, and it takes a long time. This is a competence that the support system also needs to acquire.” (P3) Addressing the provider and the need of including an understanding of equity and impartiality into the HAT philosophy was mentioned by several clinicians. Generosity and tolerance emerged as fundamental principles in the clinic’s treatment philosophy from the interviews. Clinicians expressed a strong desire to offer multiple chances for patients to succeed, saying that “…we often give many chances because we really want them to succeed, and many do get over that hump.” (P2) On the other hand, not all clinicians shared this optimism, however, with one expressing a more pessimistic outlook:“…that’s just how they are. We are not going to change them by snapping our fingers.” (P6) This reflects a degree of therapeutic realism that sits in tension with the broadly compassionate and generous orientation expressed by the majority of clinicians, illustrating that attitudes toward patient change were not uniform across the workforce. The complexities associated with substance use disorders were well understood among clinicians, particularly concerning the pervasive misunderstandings about drug interactions and behaviours in intoxication. As one clinician articulated, “They also take other drugs, and there was a sort of expectation among us, that they should just cut that out, of course. I just felt that there was such a lack of understanding of substance use disorders in a way, and how one behaves in active addiction.” (P19). On the other hand, the interviewees had the impression that the clinics have also learned from past practices that imposed strict rules and expectations on patient behaviour. Clinicians reflected on this evolution in their approach, with one remarking, “Sometimes we are very square [rigid], it became very much like the old-fashioned OAT from the 90s in the way we ran the service. There were many consequences and punishments if one did not behave as one would wish them to. Sometimes we excluded patients because they actually showed symptoms of their addiction, or we would decide how they should take the heroin, or they only received tablets, for example, or you are only allowed to inject it into your muscles, you are not allowed to inject it into wherever [you want]. But we have learned a lot over time…” (P17). This insight reflects the importance of evolving treatment approaches that not only accommodate the realities of substance use but also recognise and embrace patients’ genuine experiences with addiction, fostering better outcomes in their treatment journeys. Discussion We aimed to explore clinicians’ perspectives on the ideal concept of HAT by analysing their descriptions of optimal treatment practices. These views were articulated through what can be understood as an underlying treatment philosophy, reflected in the four identified themes, of which three were interrelated. The findings related to the first theme underscore the philosophy of HAT as one that prioritises individualisation and patient-centred care. Clinicians articulated the importance of creating a supportive environment tailored to the unique needs of each patient. This aligns with contemporary views in addiction treatment [22] and was also valued by patients in the Middlesbrough HAT study [23], where individualised approaches were associated with improved patient experiences and outcomes. Clinicians emphasised the necessity of determining each patient’s intoxication status and overall condition through regular evaluations, showing a commitment to personalised care. One clinician’s example of making an exception for a patient who wanted to participate in spinning at the gym demonstrates this individualised response to patient needs, reinforcing the idea that treatment should not impose rigid structures but should accommodate patients’ life circumstances and preferences. This practice of frequent assessment allows flexibility in treatment plans, adapting to the changing needs of patients but requires on the other hand also extensive human resources. However, clinicians reported that informal yet meaningful interactions, such as discussing current events or personal feelings also contributed to building trust and a feeling of security, which are vital for treatment engagement. The establishment of reliable relationships, as highlighted by the clinicians, underscores the need for consistent engagement, which research suggests is a key factor for therapeutic success in substance use treatments [24, 25]. These positive interactions help humanise the treatment process, shifting perceptions from seeing patients merely as cases to recognising their individuality and humanity. Another important component of the ideal HAT philosophy identified in the findings is the promotion of patient autonomy. Clinicians recognised that empowering patients to engage in their treatment process fosters a sense of ownership and agency that can mitigate feelings of powerlessness often associated with addiction. As one clinician observed, a supportive and purposeful relationship helps reduce the likelihood of conflict and promotes constructive dialogue, suggesting that a respectful approach to patient care can lead to better behavioural outcomes. The emphasis on patient autonomy is supported by research that indicates when patients feel supported and valued, they are more likely to achieve their treatment goals [26]. However, it is important to distinguish between autonomy as a philosophical ideal and its enactment in practice. Within HAT, core treatment decisions, such as dosing, remain under clinical authority, and clinicians themselves acknowledged that patients sometimes had to advocate strongly for their preferences. This tension between the ideal of autonomy and the inherent power asymmetry of a medically supervised treatment warrants critical reflection, and suggests that future HAT programmes might consider more structured mechanisms for incorporating patient preferences into treatment decisions. The call for more time and support in discovering patients’ strengths and aspirations reflects a broader trend in addiction treatment toward a holistic model that emphasises an understanding of patients’ desires. The role of a holistic and interdisciplinary approach, which crystallised in the second theme, seemed to play a central role in shaping the philosophy of HAT. This holistic perspective marks a significant shift from traditional treatment paradigms, emphasising a more comprehensive view of patient care. This aligns also with the biopsychosocial model of care, which suggests that addressing psychological and social factors alongside medical treatment is associated with more substantial and sustainable recovery outcomes [27]. Clinicians highlighted the necessity of integrating medical, social, and psychological support, reflecting a comprehensive understanding of the multifaceted nature of addiction. This perspective is also advocated by Green and colleagues who present an accessible yet comprehensive theoretical model that integrates empirical evidence about addiction aetiology and recovery using the nature-nurture paradigm [28]. They consider not only the biomedical aspects of substance use disorders but also the social and psychological dimensions that contribute to recovery. Clinicians also expressed a desire to foster effective communication and teamwork among various professionals to meet the diverse needs of patients. HAT should extend beyond merely administering medication to encompass a broad spectrum of support services, including housing assistance, financial advice, and access to healthcare. This aligns with findings from studies that indicate successful HAT programs are those that provide wraparound services, addressing the complex and often interrelated challenges faced by individuals diagnosed with OUD [7, 10, 29]. The desire for a broader treatment framework was echoed by clinicians who recognised the inadequacy of solely increasing and decreasing the diacetylmorphine dosages. Instead, they advocated for psycho-educational approaches that empower patients to understand their conditions and develop emotional resilience. This shift away from a purely pharmacological approach to a more integrated model of care resonates with the emerging literature that underscores the importance of patient education and engagement in achieving positive treatment outcomes [10, 30]. Furthermore, the emphasis on promoting social support and encouraging patient participation in social activities highlights the potential of social integration as a vital component in the treatment process. The findings reflect a commitment to interdisciplinary collaboration as a cornerstone of holistic HAT delivery. Clinicians recognised the value of working together across professional boundaries, though they also acknowledged existing barriers that hinder effective collaboration. It is essential to consider how these barriers may impact the overall treatment philosophy being enacted in practice. The need for coordinated care teams, as expressed by several clinicians, is supported by a study by Kools et al. who evaluated an interdisciplinary treatment for alcohol use disorders initiative at a general hospital department [31], indicating that interdisciplinary approaches in addiction treatment enhance access to comprehensive care and improve patient outcomes. Collaborative efforts, including case-meetings with stakeholders involved in patients’ care pathways, may be key to creating a seamless and holistic treatment experience for patients in HAT. While many clinicians expressed optimism about the potential for more comprehensive services, it is clear, that systematic barriers remain. These barriers can limit the extent to which clinicians can engage with patients holistically and address non-medical factors critical to treatment and recovery. The expressed desire to utilise clinic downtime for patient support, as mentioned by one clinician, reveals an awareness of underutilised resources that could enhance patient experiences and outcomes. Addressing these organisational constraints is essential for realising the ideal vision of HAT as a patient-centred and holistic treatment model. The third theme reveals flexibility as a fundamental component of the ideal HAT philosophy. Clinicians expressed a strong desire for the treatment model to adapt dynamically to the evolving needs of a diverse patient population, emphasising how flexible service structures could enhance accessibility and overall patient care. This theme connects with the preceding themes of individualised care and a holistic, interdisciplinary approach, supporting the notion that the ideal HAT should be responsive and adaptable. The emphasis on flexible service hours to accommodate the atypical schedules and complex lives of patients highlights a critical barrier to treatment access that must be addressed. This advocacy for accessibility aligns with the patient-centred approach discussed in the first theme, where tailoring treatment to individual needs may improve adherence and outcomes. A recent Italian study has demonstrated that flexible treatment options increase retention rates and overall satisfaction in opioid agonist treatment programs [32]. Thus, incorporating such flexibility into HAT could further enhance its success in managing opioid dependence. Moreover, the clinicians’ reflections on the ongoing learning process required – as HAT is a new treatment option in Norway – to meet patient needs, which also supports the necessity for an adaptive mindset within the HAT program. As they navigate the complexities of differentiating between stabilisation on prescribed medication and continued illicit drug use, clinicians illustrated the importance of evolving practices based on real-world experiences. This continuous adaptation not only underscores the significance of flexibility but also ties closely to the holistic approach, discussed in the second theme. Clinicians noted that rigid adherence to protocols can hinder the delivery of personalised care, indicating a need for more fluid practices that evolve with patient needs. This need for procedural flexibility is echoed in current literature, which suggests that successful opioid agonist treatment should be individualised and evolve based on patient feedback and changing circumstances [33, 34]. It is worth noting that the aspiration for flexibility was not universally shared. Some clinicians were more cautious, seeing consistent structure as essential for safety and predictability in a complex clinical environment. This reflects a broader tension in addiction treatment between person-centred adaptability and the institutional need for clear boundaries, and suggests that agreeing on the appropriate degree of flexibility may itself be an important area for team reflection and clinical governance within HAT programmes. The fourth theme, which centres on incorporating substance use as a reality, offers a perspective on the complexities that clinicians face in HAT. Acknowledging the often straightforward motivations behind patients’ engagement with HAT reveals a necessary realism in treatment philosophy. This perspective not only shows the inherent challenges in caring for individuals with substance use disorders but also raises important questions about the foundational attitudes guiding clinical practices. Instead of adopting a punitive or moralistic stance, clinicians wish a more compassionate approach that considers the lived experiences of their patients. It is worth considering what structural and cultural conditions enable or constrain this evolution. As a pilot project with an explicit evaluative mandate, the Norwegian HAT programme may foster greater critical reflection and practice change than permanent services. Working in a developing treatment programme may also place higher expectations on clinicians to learn and adapt, normalising self-questioning and openness to change. The interdisciplinary team composition in HAT, including social workers, psychologists and physicians working alongside nurses, may further support a cultural shift away from purely biomedical framings of addiction toward more compassionate, socially informed perspectives. On the contrary, the same structural features that constrain themes 1 to 3 like limited resources, rigid protocols, and institutional pressures may also slow down the cultural evolution that clinicians describe. The persistence of stigmatising assumptions, even among clinicians who actively reflect on their own prejudices, suggests that individual self-awareness alone is insufficient without broader organisational and systemic support for cultural change. This points to the need for structured supervision, ongoing training in stigma awareness, and explicit institutional framing of HAT as a harm reduction rather than compliance-oriented intervention. These concerns are echoed in recent discussions about stigma and the role it plays in treatment dynamics [35, 36]. Reflecting on how stigma can shape both patient experience and clinician attitudes is essential for developing a more inclusive treatment environment. Contemporary addiction treatment research underlines the importance of understanding addiction as a complex interplay of biological, psychological, and social factors rather than merely a series of moral failings or individual choices [37]. By embracing this understanding, HAT can spin towards a more empathetic framework that reinforces the value of support and tolerance, which emerged as fundamental principles from the clinicians’ insights. The discussions on language and terminology the clinicians described, also reflects how stigma affects treatment outcomes. A literature review on stigma toward people with substance use disorder has shown that the labels applied to individuals can significantly affect their self-perception, treatment engagement, and the attitudes of healthcare providers [38]. By being mindful of the terminology, clinicians may foster a more inclusive treatment environment. Furthermore, the clinicians’ reflections on their own prejudices and the pervasive stigma surrounding addiction show the need for continuous self-awareness and professional development within HAT. Stigmatising preconceptions occasionally surfaced even within narratives that clinicians framed positively, such as expressions of surprise at the absence of violence among patients. This illustrates how stigma may operate subtly and often without conscious awareness. By actively challenging their biases and striving for a more open-minded approach, clinicians can create a therapeutic environment that acknowledges the complex realities of addiction, moving away from a one-size-fits-all model of care [39]. However, clinicians recognised the evolution of their treatment philosophies over time, moving away from punitive measures and towards a more supportive, understanding framework. This willingness to adapt treatment protocols to align with patients’ social realities signifies a departure from more restrictive, traditional practices often seen in earlier models of opioid agonist treatment [33, 40]. Harm reduction strategies support this flexible approach, indicating that accommodating social and cultural contexts can encourage patient adherence and improve overall satisfaction and treatment outcome [41]. Across all four themes, a recurring finding is the presence of systemic barriers and challenges that clinicians face in realising their ideal treatment philosophies. Issues such as rigid protocols, inadequate communication channels among professionals, and institutional pressures that prioritise compliance over individualised care. These barriers may hinder their ability to provide the personalised, flexible, and holistic treatment models they envision for their patients. For instance, while the call for individualised care and a holistic approach is strong, the reality of healthcare systems often imposes rigid structures that can stifle adaptability and responsiveness. The acknowledgment of these barriers is important, as it highlights the gap between the ideal and the current state of treatment delivery. Together, the four themes reveal a coherent treatment philosophy among clinicians, which is person-centred, holistic, flexible, and grounded in a non-judgmental understanding of addiction. Yet the recurring tension across all themes between what clinicians believe HAT ought to be and what they are able to provide in practice is perhaps the most significant finding of this study. This gap is not primarily a matter of individual clinical skill or motivation, as clinicians are clearly reflective and committed, but reflects structural and organisational conditions that constrain the realisation of their ideals. For the further programme development, this suggests that investing in clinician training and philosophy alone is insufficient; the organisational framework within which HAT is delivered must itself be aligned with the treatment philosophy it is meant to embody. For policy, this points to the importance of translating the aspirational values of the Norwegian HAT, individualisation, flexibility, harm reduction, and patient dignity, into concrete operational standards, commissioning frameworks, and resource allocations that make those values achievable in practice rather than merely aspirational. Strengths and limitations The diversity of the study population is a key strength of this study. By including clinicians with background in different disciplines and hierarchies (nurse, social workers, leaders and physicians) and former employees, this research captures a wide array of experiences and challenges faced when providing HAT. However, this study is not without its limitations. Recruitment was facilitated by the charge nurse in Oslo and by the first author’s presence in Bergen, which may have influenced who participated and the candour of responses. However, as we aimed to interview the entire clinician workforce across both clinics, self-selection bias is considered minimal. Individual interviews were chosen over focus groups to maximise openness, and the inclusion of former clinicians provided additional perspectives free from current workplace constraints. While the diversity of the clinicians adds richness, it is possible that the insights reflect only the specific contexts of the HAT environments in Norway and may not be transferable to other countries which provide HAT. Additionally, although quotes were translated with care, nuances inherent in the original Norwegian might be lost, potentially affecting the interpretation of participants’ comments. Furthermore, while purposive sampling enabled the inclusion of a range of perspectives, it also carries the inherent risk of bias, as it depends on the researchers’ judgments in selecting participants. While interviews with current clinicians were conducted within the clinical setting, the individual interview format was chosen to provide a safer space for open expression than focus groups conducted with colleagues present. In light of these strengths and limitations, the study offers valuable insights into clinicians’ experiences and perceptions surrounding HAT, contributing to the understanding of HAT and highlighting key areas for ongoing exploration and refinement in addiction treatment approaches. Conclusion and practical implications This study extends our previous research on clinician experiences in Norwegian HAT by moving beyond descriptions of daily challenges and rewards to explore the underlying treatment philosophy that guides clinicians’ ideals. The insights from the clinicians gave a comprehensive vision for HAT to be rooted in the principles of individualisation, holistic care, flexibility, and a realistic understanding of substance use. According to the interviewees, an ideal HAT program is one that incorporates patients as individuals, fostering autonomy and relationship-building to enhance engagement in their recovery journeys. Moreover, a successful HAT program should adopt a holistic, interdisciplinary approach, integrating medical, psychological, and social supports. This framework not only addresses the multifaceted challenges of addiction but is also perceived by clinicians as supporting recovery pathways. Emphasising collaboration among healthcare professionals will help overcome the structural barriers that often hinder the provision of comprehensive care. Flexibility emerges as a cornerstone of the HAT philosophy, underscoring the importance of adapting treatment strategies to accommodate the dynamic realities of patients’ lives. Clinicians may be empowered to modify protocols and practices based on real-world experiences, ensuring that care remains responsive and compassionate. By doing so, HAT might better meet the diverse needs of its patient population. Finally, recognising substance use as a reality is important for cultivating an environment of empathy and understanding within HAT. Clinicians’ self-awareness and sensitivity in their language and approach can significantly impact the treatment dynamics, fostering a more inclusive atmosphere that encourages patient engagement. Addressing systemic challenges will be necessary for realising a patient-centred model of HAT, paving the way for improved patient outcomes and satisfaction. Specifically, this points to the value of protected time for interdisciplinary case discussions, structured stigma awareness training as part of clinical onboarding, and organisational policies that formally permit flexible responses to individual patient circumstances rather than treating them as exceptions. The clinicians’ insights signal a need for policy changes and resource allocation that empower clinicians to implement more comprehensive and adaptable care strategies within OAT frameworks. Ongoing research will be vital in guiding the evolution of HAT and its implementation in the Norwegian OAT by generating knowledge on patient outcomes, service organisation, and clinical practice, thereby supporting the recovery of this vulnerable population.